(Q46520529)
Statements
1 reference
Eighteen-month follow-up of intravitreal bevacizumab in type 2 idiopathic macular telangiectasia (English)
1 reference
1 reference
1 reference
F G Holz
1 reference
H P N Scholl
1 reference
1 July 2008
1 reference
1 reference
92
1 reference
7
1 reference
941-945
1 reference
Identifiers
1 reference
1 reference